20+ full codes, 2,400+ articles translated and updated. Case law linked to every article. Read the actual text before you ask a lawyer about it — free, no login required.
20+
french codes
Fully translated
2,400+
articles in English
Updated regularly
480+
court rulings linked
Per article
Free
full access
No login required
Showing 7471–7480 of 32667 articles for “Art. Cass. 3e Civ. 13-5-1998 n° 70”
Generic proprietary medicinal products whose active substance(s) is/are exclusively one or more mineral substances are covered by the provisions of articles R. 5121-5, R. 5121-5-1 and R. 5121-5-2.
Unless there is a risk to patients' health, proprietary medicinal products which fulfil the conditions for being a reference proprietary medicinal product in an existing generic group may, by decision…
For the application of 2° of I of Article L. 561-5, and by way of derogation from Article R. 561-5-2, when the measures provided for in 1° to 3° of Article R. 561-5-1 cannot be implemented: 1° The per…
The members of the Board of Directors of the guarantee fund, as well as any person who, by virtue of their duties, has access to documents and information held by the guarantee fund, are bound by prof…
Without prejudice to the information required by other legislative or regulatory provisions, the container and packaging of each unit of tattooing product placed on the market free of charge or agains…
The purpose of the aptitude test to which the Prefect may decide to subject the applicant in whole or in part, under the conditions laid down in article R. 212-90-1 and in 3° of article R. 212-93, is…
Where available, the certified information referred to in article L. 4371-5-1 is used in lieu of supporting documents to fulfil the obligations set out in article L. 4371-5.
I.-The Committee meets when convened by its Chairman or at the request of the majority of its full members. The Chairman sets the agenda, based on the annual work programme adopted by the Committee an…
When a new indication is authorised by the Agence nationale de sécurité du médicament et des produits de santé, on the basis of preclinical and clinical studies considered significant during the scien…
When a change in the classification mentioned in 1° of Article R. 5121-36 is authorised, on the basis of preclinical and clinical studies considered to be significant during the scientific evaluation…
Avocate au Barreau de Paris
Toque #C2396
15+ Years In French Corporate Practice
English · French · Russian
Ready When You Are
A 20–30 minute call, in English, to scope the engagement. No obligation, no preliminary fee. You will leave the call with a clear view of what the work will cover and what it will cost.
20+ full codes and 2,400+ articles in English, with the key court rulings linked to every article — free to read.
Read MoreA lawyer-reviewed report explaining how the relevant articles apply to your situation, with case-law analysis and next steps.
Read MoreScope your matter with a Paris-Bar avocate — incorporation, contracts, disputes — handled bilingually, end to end.
Read More
